Apogee Therapeutics's top three insider shareholders as of May 14, 2026 are Nimish P Shah (Director, 1.75Mn shares), Nimish P Shah (Director, 1.75Mn shares), Nimish P Shah (Director, 1.75Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Nimish P Shah | - | 0 | 1,750,000 | 17 Jul, 2023 |
| Nimish P Shah | - | 0 | 1,750,000 | 17 Jul, 2023 |
| Nimish P Shah | - | 0 | 1,750,000 | 17 Jul, 2023 |
| Michael Thomas Henderson | Chief Executive Officer | 1,135,987 | 0 | 20 Apr, 2026 |
| Michael Thomas Henderson | Chief Executive Officer | 1,132,987 | 0 | 10 Apr, 2026 |
| Funds Management Llc Fairmount | - | 0 | 298,647 | 22 Jan, 2026 |
| Carl Dambkowski | Chief Medical Officer | 208,398 | 0 | 03 Apr, 2026 |
| Jane Henderson | Chief Financial Officer | 177,371 | 0 | 03 Apr, 2026 |
| Jane Henderson | Chief Financial Officer | 177,371 | 0 | 03 Apr, 2026 |
| Jane Henderson | Chief Financial Officer | 175,371 | 0 | 17 Apr, 2026 |
| Funds Management Llc Fairmount | - | 0 | 102,332 | 31 Jan, 2024 |
| Mark C. Mckenna | - | 20,000 | 0 | 16 Dec, 2024 |
| Mark C. Mckenna | - | 20,000 | 0 | 16 Dec, 2024 |
| Mark C. Mckenna | - | 20,000 | 0 | 16 Dec, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Apr, 2026 | Michael Thomas Henderson | Common Stock | A | 3,000 | $22.86 | 1,135,987 | D | M |
| 16 Apr, 2026 | Michael Thomas Henderson | Stock Option (Right to Buy) | D | 3,000 | $0.00 | 387,012 | D | M |
| 16 Apr, 2026 | Jane Henderson | Common Stock | D | 2,000 | $90.00 | 175,371 | D | S |
| 08 Apr, 2026 | Michael Thomas Henderson | Common Stock | D | 17,800 | $82.48 | 1,135,187 | D | S |
| 08 Apr, 2026 | Michael Thomas Henderson | Common Stock | D | 17,800 | $82.48 | 1,135,187 | D | S |
| 08 Apr, 2026 | Michael Thomas Henderson | Common Stock | D | 2,000 | $83.26 | 1,133,187 | D | S |
| 08 Apr, 2026 | Michael Thomas Henderson | Common Stock | D | 2,000 | $83.26 | 1,133,187 | D | S |
| 08 Apr, 2026 | Michael Thomas Henderson | Common Stock | D | 200 | $85.00 | 1,132,987 | D | S |
| 08 Apr, 2026 | Michael Thomas Henderson | Common Stock | D | 200 | $85.00 | 1,132,987 | D | S |
| 01 Apr, 2026 | Carl Dambkowski | Common Stock | A | 4,125 | $22.86 | 213,898 | D | M |
| 01 Apr, 2026 | Jane Henderson | Common Stock | D | 900 | $84.46 | 178,471 | D | S |
| 01 Apr, 2026 | Jane Henderson | Common Stock | D | 900 | $84.46 | 178,471 | D | S |
| 01 Apr, 2026 | Jane Henderson | Common Stock | D | 900 | $84.46 | 178,471 | D | S |
| 01 Apr, 2026 | Carl Dambkowski | Common Stock | D | 2,698 | $84.31 | 211,200 | D | S |
| 01 Apr, 2026 | Jane Henderson | Common Stock | D | 1,100 | $85.46 | 177,371 | D | S |
| 01 Apr, 2026 | Jane Henderson | Common Stock | D | 1,100 | $85.46 | 177,371 | D | S |
| 01 Apr, 2026 | Jane Henderson | Common Stock | D | 1,100 | $85.46 | 177,371 | D | S |
| 01 Apr, 2026 | Carl Dambkowski | Common Stock | D | 2,702 | $85.33 | 208,498 | D | S |
| 01 Apr, 2026 | Carl Dambkowski | Common Stock | D | 100 | $85.89 | 208,398 | D | S |
| 01 Apr, 2026 | Carl Dambkowski | Stock Option (Right to Buy) | D | 4,125 | $0.00 | 127,165 | D | M |